0000919574-23-003425.txt : 20230519 0000919574-23-003425.hdr.sgml : 20230519 20230519210050 ACCESSION NUMBER: 0000919574-23-003425 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230517 FILED AS OF DATE: 20230519 DATE AS OF CHANGE: 20230519 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Casdin Partners Master Fund, L.P. CENTRAL INDEX KEY: 0001534265 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34180 FILM NUMBER: 23942214 BUSINESS ADDRESS: STREET 1: WALKER HOUSE STREET 2: 87 MARY STREET CITY: GEORGE TOWN STATE: E9 ZIP: KY1-9001 BUSINESS PHONE: 212.300.5575 MAIL ADDRESS: STREET 1: WALKER HOUSE STREET 2: 87 MARY STREET CITY: GEORGE TOWN STATE: E9 ZIP: KY1-9001 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Casdin Partners GP, LLC CENTRAL INDEX KEY: 0001534260 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34180 FILM NUMBER: 23942212 BUSINESS ADDRESS: STREET 1: 1350 AVENUE OF THE AMERICAS STREET 2: SUITE 1140 CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212.300.5575 MAIL ADDRESS: STREET 1: 1350 AVENUE OF THE AMERICAS STREET 2: SUITE 1140 CITY: NEW YORK STATE: NY ZIP: 10019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Casdin Capital, LLC CENTRAL INDEX KEY: 0001534261 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34180 FILM NUMBER: 23942213 BUSINESS ADDRESS: STREET 1: 1350 AVENUE OF THE AMERICAS STREET 2: SUITE 2600 CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212.300.5575 MAIL ADDRESS: STREET 1: 1350 AVENUE OF THE AMERICAS STREET 2: SUITE 2600 CITY: NEW YORK STATE: NY ZIP: 10019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Casdin Partners FO1-MSV, LP CENTRAL INDEX KEY: 0001938709 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34180 FILM NUMBER: 23942209 BUSINESS ADDRESS: STREET 1: C/O CASDIN PARTNERS GP, LLC STREET 2: 1350 AVENUE OF THE AMERICAS, SUITE 2600 CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212-897-5430 MAIL ADDRESS: STREET 1: C/O CASDIN PARTNERS GP, LLC STREET 2: 1350 AVENUE OF THE AMERICAS, SUITE 2600 CITY: NEW YORK STATE: NY ZIP: 10019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Casdin Private Growth Equity Fund II, L.P. CENTRAL INDEX KEY: 0001891102 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34180 FILM NUMBER: 23942211 BUSINESS ADDRESS: STREET 1: 1350 AVENUE OF THE AMERICAS STREET 2: SUITE 2600 CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: (212) 897-5430 MAIL ADDRESS: STREET 1: 1350 AVENUE OF THE AMERICAS STREET 2: SUITE 2600 CITY: NEW YORK STATE: NY ZIP: 10019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Casdin Private Growth Equity Fund II GP, LLC CENTRAL INDEX KEY: 0001919480 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34180 FILM NUMBER: 23942210 BUSINESS ADDRESS: STREET 1: 1350 AVENUE OF THE AMERICAS, SUITE 2600 CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212-897-5430 MAIL ADDRESS: STREET 1: 1350 AVENUE OF THE AMERICAS, SUITE 2600 CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: STANDARD BIOTOOLS INC. CENTRAL INDEX KEY: 0001162194 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 770513190 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 TOWER PLACE STREET 2: SUITE 2000 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6502666000 MAIL ADDRESS: STREET 1: 2 TOWER PLACE STREET 2: SUITE 2000 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: FLUIDIGM CORP DATE OF NAME CHANGE: 20011113 4 1 ownership.xml X0407 4 2023-05-17 0 0001162194 STANDARD BIOTOOLS INC. LAB 0001534265 Casdin Partners Master Fund, L.P. 1350 AVENUE OF THE AMERICAS SUITE 2600 NEW YORK NY 10019 1 0 1 0 0001534261 Casdin Capital, LLC 1350 AVENUE OF THE AMERICAS SUITE 2600 NEW YORK NY 10019 1 0 1 0 0001534260 Casdin Partners GP, LLC 1350 AVENUE OF THE AMERICAS SUITE 2600 NEW YORK NY 10019 1 0 1 0 0001891102 Casdin Private Growth Equity Fund II, L.P. 1350 AVENUE OF THE AMERICAS SUITE 2600 NEW YORK NY 10019 1 0 0 0 0001919480 Casdin Private Growth Equity Fund II GP, LLC 1350 AVENUE OF THE AMERICAS, SUITE 2600 NEW YORK NY 10019 1 0 0 0 0001938709 Casdin Partners FO1-MSV, LP C/O CASDIN PARTNERS GP, LLC 1350 AVENUE OF THE AMERICAS, SUITE 2600 NEW YORK NY 10019 1 0 0 0 0 Common Stock 2023-05-17 4 P 0 250000 1.8862 A 250000 I See footnote Common Stock 2023-05-18 4 P 0 150000 2.1591 A 400000 I See footnote Common Stock 2023-05-19 4 P 0 800000 2.2949 A 1200000 I See footnote The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions within the range of $1.855 to $1.9237. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. The securities are owned directly by Casdin Partners FO1-MSV, LP ("Casdin FO1") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to Casdin FO1, (ii) Casdin Partners GP, LLC, the general partner of Casdin FO1, and (iii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions within the range of $2.1489 to $2.1759. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions within the range of $2.29 to $2.2982. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Eli Casdin has been deputized to represent the Reporting Persons on the board of directors of the Issuer. By virtue of Mr. Casdin's representation, for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act"), each of the Reporting Persons may be deemed directors by deputization of the Issuer. Mr. Casdin files separate Section 16 reports disclosing securities of the Issuer that he may be deemed to beneficially own for Section 16 purposes. Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Casdin Partners Master Fund, LP By: Casdin Partners GP, LLC, its General Partner By: /s/ Eli Casdin, Managing Member 2023-05-19 Casdin Capital LLC By: /s/ Eli Casdin, Managing Member 2023-05-19 Casdin Partners GP LLC By: /s/ Eli Casdin, Managing Member 2023-05-19 Casdin Private Growth Equity Fund II, L.P. By: Casdin Private Growth Equity Fund II GP, LLC, its General Partner By: /s/ Eli Casdin, Managing Member 2023-05-19 Casdin Private Growth Equity Fund GP II, LLC By: /s/ Eli Casdin, Managing Member 2023-05-19 Casdin Partners FO1-MSV, LP By: Casdin Partners GP, LLC, its General Partner By: /s/ Eli Casdin, Managing Member 2023-05-19